Found: 32
Select item for more details and to access through your institution.
Integrated stress response and immune cell infiltration in an ibrutinib‐refractory mantle cell lymphoma patient following ONC201 treatment.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 133, doi. 10.1111/bjh.15271
- By:
- Publication type:
- Article
CD8 Co-receptor promotes susceptibility of CD8 T cells to transforming growth factor-β (TGF-β)-mediated suppression.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 291, doi. 10.1007/s00262-010-0962-6
- By:
- Publication type:
- Article
Oncolytic viruses: a new class of immunotherapy drugs.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 9, p. 642, doi. 10.1038/nrd4663
- By:
- Publication type:
- Article
Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1497, doi. 10.3390/vaccines9121497
- By:
- Publication type:
- Article
A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors.
- Published in:
- European Journal of Medical Research, 2022, v. 27, n. 1, p. 1, doi. 10.1186/s40001-022-00732-w
- By:
- Publication type:
- Article
MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 471, p. 1, doi. 10.1126/scitranslmed.aau0417
- By:
- Publication type:
- Article
Intratumoral Influenza Vaccine Administration Attenuates Breast Cancer Growth and Restructures the Tumor Microenvironment through Sialic Acid Binding of Vaccine Hemagglutinin.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 1, p. 225, doi. 10.3390/ijms25010225
- By:
- Publication type:
- Article
Memory Precursors and Short-Lived Effector T cell Subsets Have Different Sensitivities to TGFβ.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3930, doi. 10.3390/ijms24043930
- By:
- Publication type:
- Article
Immunobiochemical Reconstruction of Influenza Lung Infection—Melanoma Skin Cancer Interactions.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00004
- By:
- Publication type:
- Article
Gut Microbial Shifts Indicate Melanoma Presence and Bacterial Interactions in a Murine Model.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 4, p. 958, doi. 10.3390/diagnostics12040958
- By:
- Publication type:
- Article
Pro-Inflammatory Chemokine CCL2 (MCP-1) Promotes Healing in Diabetic Wounds by Restoring the Macrophage Response.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091574
- By:
- Publication type:
- Article
Integrated stress response and immune cell infiltration in an ibrutinib‐refractory mantle cell lymphoma patient following ONC201 treatment.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 1, p. 133, doi. 10.1111/bjh.15271
- By:
- Publication type:
- Article
Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-113
- By:
- Publication type:
- Article
Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 174, p. 1, doi. 10.1126/scitranslmed.3005127
- By:
- Publication type:
- Article
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2018, v. 31, n. 4, p. 534, doi. 10.1111/pcmr.12694
- By:
- Publication type:
- Article
HSP70i is a critical component of the immune response leading to vitiligo.
- Published in:
- Pigment Cell & Melanoma Research, 2012, v. 25, n. 1, p. 88, doi. 10.1111/j.1755-148X.2011.00916.x
- By:
- Publication type:
- Article
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Overriding impaired FPR chemotaxis signaling in diabetic neutrophil stimulates infection control in murine diabetic wound.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.72071
- By:
- Publication type:
- Article
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma.
- Published in:
- Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01483
- By:
- Publication type:
- Article
Editorial: Tumor Microenvironment and Resistance to Current Therapies.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
IFN-λ: A New Inducer of Local Immunity against Cancer and Infections.
- Published in:
- Frontiers in Immunology, 2016, v. 7, p. 1, doi. 10.3389/fimmu.2016.00598
- By:
- Publication type:
- Article
Talimogene Laherparepvec (T-VEC) as Cancer Immunotherapy.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2017, v. 8, p. 14
- By:
- Publication type:
- Article
A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1405, doi. 10.1007/s00262-022-03314-1
- By:
- Publication type:
- Article
Low-dose interleukin-2 impairs host anti-tumor immunity and inhibits therapeutic responses in a mouse model of melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 9, doi. 10.1007/s00262-016-1916-4
- By:
- Publication type:
- Article
Priming with very low-affinity peptide ligands gives rise to CD8 T-cell effectors with enhanced function but with greater susceptibility to transforming growth factor (TGF)β-mediated suppression.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 11, p. 1543, doi. 10.1007/s00262-011-1043-1
- By:
- Publication type:
- Article
Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2923, doi. 10.3390/cancers14122923
- By:
- Publication type:
- Article
NKG2D signaling on CD8<sup>+</sup> T cells represses T-bet and rescues CD4-unhelped CD8<sup>+</sup> T cell memory recall but not effector responses.
- Published in:
- Nature Medicine, 2012, v. 18, n. 3, p. 422, doi. 10.1038/nm.2683
- By:
- Publication type:
- Article
Talimogene Laherparepvec (T-VEC) as Cancer Immunotherapy.
- Published in:
- Personalized Medicine in Oncology, 2017, v. 6, n. 1, p. 21
- By:
- Publication type:
- Article
Seasonal influenza vaccines differentially activate and modulate toll-like receptor expression within the tumor microenvironment.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1308651
- By:
- Publication type:
- Article
Oncolytic Viruses--Natural and Genetically Engineered Cancer Immunotherapies.
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00202
- By:
- Publication type:
- Article
DDIS-16. ONC201 IN COMBINATION WITH RADIATION EXHIBITS SYNERGISTIC EFFICACY IN HIGH GRADE GLIOMAS AND OTHER ADVANCED CANCERS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi72, doi. 10.1093/neuonc/noy148.295
- By:
- Publication type:
- Article
Attenuated Dengue virus PV001-DV induces oncolytic tumor cell death and potent immune responses.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04344-8
- By:
- Publication type:
- Article